Authors: Heslop, H Rooney, C Brenner, M Krance, R Carrum, G Gahn, B Bollard, C Khan, S Gee, A Popat, U Gresik, M Przepiorka, D Kuehnle, I Grilley, B

Citation: H. Heslop et al., Clinical protocol - Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease, HUM GENE TH, 11(10), 2000, pp. 1465-1475